Systemic review of hyperbaric oxygen therapy for radiation-induced skin necrosis
Study finds that hyperbaric oxygen therapy (HBOT) reduced the symptom burden of patients receiving radiation therapy
With over half a million Americans receiving radiation therapy for cancer each year, damage to skin tissues within the radiation field are a common occurrence with longer term serious sequelae, such as reduced vascularity, tissue necrosis and fibrosis, and skin atrophy, which is found in between 5% and 15% of patients.
Hyperbaric oxygen therapy (HBOT), where the patient breathes 100% oxygen at pressures greater than one atmosphere in a hermetic chamber, is frequently employed as adjuvant management; the putative mechanisms of action include promoting angiogenesis and augmenting development of collagen. This study reviewed the evidence for effectiveness of this modality.
Using the preferred reporting items for systematic reviews and meta-analysis guidelines, eight papers met the inclusion...
Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Cancer Nursing Practice
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests